{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T12:40:09Z","timestamp":1780058409594,"version":"3.54.0"},"reference-count":115,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzen Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Influenza viruses cause approximately 3 to 5 million severe cases and tens of thousands of deaths globally each year, posing a continuous threat to public health. Nanoparticles with superior biocompatibility, combined with traditional Chinese herbal medicine could offer promising avenues to enhance therapeutic efficacy, improve targeting precision, and address multidrug resistance. This study aims to provide a comprehensive review of the current status and future directions of nanoparticle applications in influenza research, thereby providing more effective and convenient solutions for influenza prevention and control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A publication search was performed using Web of Science Core Collection, Scopus, and PubMed from 2005 to 2025 to improve the completeness of publications collection. Bibliometric analyses performed using Bibliometrix, CiteSpace, and VOSviewer software to compensate for the differences in their respective algorithms. The analysis by evaluating publication quantity, Citation Counts, and Co-authorship status to find the core institutions, journals, and key authors. Explore the research hotspots of nanoparticles and influenza through keyword analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>A total of 3,478 relevant publications were identified. The United States and China were the primary contributors in terms of publication volume, with the Chinese Academy of Sciences leading in institutional contributions. Vaccines emerged as the top-performing journal in this field. Masaru Kanekiyo\u2019s article had the highest local citation count, and he was identified as the author with the greatest individual contribution. Keyword analysis revealed that optimizing delivery systems and advancing vaccine development are central research priorities. Notably, bibliometric analysis revealed that besides metal-based nanoparticles, viral-like particles, polymer nanoparticles, and lipid nanoparticles in the field of delivery system research, herbal small-molecule nanoparticle delivery system has garnered significant attention due to the promise for future clinical applications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Research on nanoparticles in influenza is rapidly advancing, with a primary focus on their application in vaccine development and delivery optimization. The field is also exploring nanoparticles from various sources. Future research should bridge basic mechanistic studies with clinical applications to enhance their impact.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1715271","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T05:38:01Z","timestamp":1768973881000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Nanoparticles in influenza research: a bibliometric analysis of global trends (2005 - 2025)"],"prefix":"10.3389","volume":"17","author":[{"given":"Yezi","family":"Zhang","sequence":"first","affiliation":[{"name":"The Third Clinical Medical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Lin","sequence":"additional","affiliation":[{"name":"The Third Clinical Medical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Wen","sequence":"additional","affiliation":[{"name":"Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaona","family":"Zhang","sequence":"additional","affiliation":[{"name":"Guangzhou University of Chinese Medicine Science and Technology Innovation Center","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Lin","sequence":"additional","affiliation":[{"name":"The Third Clinical Medical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghua","family":"Liu","sequence":"additional","affiliation":[{"name":"The Third Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Liu","sequence":"additional","affiliation":[{"name":"Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Xu","sequence":"additional","affiliation":[{"name":"The Third Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingdong","family":"Lin","sequence":"additional","affiliation":[{"name":"The Third Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhizhun","family":"Mo","sequence":"additional","affiliation":[{"name":"Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp058281","article-title":"The origins of pandemic influenza \u2014 lessons from the 1918 virus","volume":"353","author":"Belshe","year":"2005","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2024.05.053","article-title":"Ecology and evolution of avian influenza viruses","volume":"34","author":"Bi","year":"2024","journal-title":"Curr Biol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy103","article-title":"A universal influenza vaccine: the strategic plan for the national institute of allergy and infectious diseases","volume":"218","author":"Erbelding","year":"2018","journal-title":"J Infect Dis"},{"key":"B4","unstructured":""},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707130","article-title":"Nanoparticles: pharmacological and toxicological significance","volume":"150","author":"Medina","year":"2007","journal-title":"Br J Pharmacol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1023\/B:BMMD.0000042053.51016.b4","article-title":"Opportunities for nanotechnology-based innovation in tissue proteomics","volume":"6","author":"Geho","year":"2004","journal-title":"BioMed Microdevices"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202411720","article-title":"Organelle-targeting nanoparticles","volume":"12","author":"Soukar","year":"2025","journal-title":"Adv Sci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41392-023-01562-w","article-title":"Gold nanoparticles combat enveloped RNA virus by affecting organelle dynamics","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct Targeted Ther"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.7150\/thno.23856","article-title":"Applications of gold nanoparticles in virus detection","volume":"8","author":"Draz","year":"2018","journal-title":"Theranostics"},{"key":"B10","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12951-024-02426-3","article-title":"Collision of herbal medicine and nanotechnology: a bibliometric analysis of herbal nanoparticles from 2004 to 2023","volume":"22","author":"Ai","year":"2024","journal-title":"J Nanobiotechnol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s40037-021-00695-4","article-title":"Bibliometrics: methods for studying academic publishing","volume":"11","author":"Ninkov","year":"2022","journal-title":"Perspect Med Educ"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2022.10.023","article-title":"Current perspectives and trend of nanomedicine in cancer: a review and bibliometric analysis","volume":"352","author":"Pei","year":"2022","journal-title":"J Ctrl Rel: Off J Ctrl Rel Soc"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/nature12202","article-title":"Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies","volume":"499","author":"Kanekiyo","year":"2013","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41467-017-02725-4","article-title":"Double-layered protein nanoparticles induce broad protection against divergent influenza a viruses","volume":"9","author":"Deng","year":"2018","journal-title":"Nat Commun"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.03.035","article-title":"Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza viruses","volume":"25","author":"Bahl","year":"2017","journal-title":"Mol Ther"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1038\/s41467-018-05482-0","article-title":"Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies","volume":"9","author":"Pardi","year":"2018","journal-title":"Nat Commun"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201001349","article-title":"Inhibition of influenza virus infection by multivalent sialic-acid-functionalized gold nanoparticles","volume":"6","author":"Papp","year":"2010","journal-title":"Small"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/1556-276X-8-93","article-title":"Antiviral activity of silver nanoparticle\/chitosan composites against H1N1 influenza a virus","volume":"8","author":"Mori","year":"2013","journal-title":"Nanoscale Res Lett"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.6b06613","article-title":"Silver nanoparticle based codelivery of oseltamivir to inhibit the activity of the H1N1 influenza virus through ROS-mediated signaling pathways","volume":"8","author":"Li","year":"2016","journal-title":"ACS Appl Mater Interfaces"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2021.08.029","article-title":"Polymeric and lipid nanoparticles for delivery of self-amplifying RNA vaccines","volume":"338","author":"Blakney","year":"2021","journal-title":"J Ctrl Rel"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e2314747121","DOI":"10.1073\/pnas.2314747121","article-title":"Precision treatment of viral pneumonia through macrophage-targeted lipid nanoparticle delivery","volume":"121","author":"Zhao","year":"2024","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.2147\/IJN.S155994","article-title":"Inhibition of H1N1 influenza virus-induced apoptosis by functionalized selenium nanoparticles with amantadine through ROS-mediated AKT signaling pathways","volume":"13","author":"Li","year":"2018","journal-title":"Int J Nanomed"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.0c04624","article-title":"The inhibition of H1N1 influenza virus-induced apoptosis by surface decoration of selenium nanoparticles with \u03b2-thujaplicin through reactive oxygen species-mediated AKT and p53 signaling pathways","volume":"5","author":"Wang","year":"2020","journal-title":"ACS Omega"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S140939","article-title":"Inhibitory activity of selenium nanoparticles functionalized with oseltamivir on H1N1 influenza virus","volume":"12","author":"Li","year":"2017","journal-title":"Int J Nanomed"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S177658","article-title":"Restriction of H1N1 influenza virus infection by selenium nanoparticles loaded with ribavirin via resisting caspase-3 apoptotic pathway","volume":"13","author":"Lin","year":"2018","journal-title":"Int J Nanomed"},{"key":"B28","doi-asserted-by":"publisher","first-page":"eadf4098","DOI":"10.1126\/sciadv.adf4098","article-title":"Polydopamine-based nanomedicines for efficient antiviral and secondary injury protection therapy","volume":"9","author":"Yin","year":"2023","journal-title":"Sci Adv"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.rinma.2025.100712","article-title":"Chemical and biological assessment of biosynthesized magnetite (Fe3O4) nanoparticles (NPs) mediated quercetin extracted from allium cepa","volume":"26","author":"Mossa Mishbak","year":"2025","journal-title":"Results Mater"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e32335","article-title":"Comparative metabolomics analysis of citrus medica var. sarcodactylis swingle and limonia acidissima linn. Fruits and leaves cultivated in Egypt in context to their antiviral effects","volume":"10","author":"El Sayed","year":"2024","journal-title":"Heliyon"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.seppur.2022.121565","article-title":"Electrospun nanofibrous membrane with antibacterial and antiviral properties decorated with myoporum bontioides extract and silver-doped carbon nitride nanoparticles for medical masks application","volume":"298","author":"Chen","year":"2022","journal-title":"Sep Purif Technol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13122174","article-title":"Nanoformulation composed of ellagic acid and functionalized zinc oxide nanoparticles inactivates DNA and RNA viruses","volume":"13","author":"AbouAitah","year":"2021","journal-title":"Pharmaceutics"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1166\/jbn.2020.2916","article-title":"Green synthesis of ZnO NPs via salvia hispanica: evaluation of potential antioxidant, antibacterial, mammalian cell viability, H1N1 influenza virus inhibition and photocatalytic activities","volume":"16","author":"Rabiee","year":"2020","journal-title":"J BioMed Nanotechnol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202103_25427","article-title":"Inhibitory effects of epigallocatechin gallate (EGCG) combined with zinc sulfate and silver nanoparticles on avian influenza A virus subtype H5N1","volume":"25","author":"Saadh","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1039\/d4dt02449d","article-title":"Green synthesis of ZnO-NPs using sugarcane bagasse waste: phytochemical assessment of extract and biological study of nanoparticles","volume":"53","author":"Suleiman","year":"2024","journal-title":"Dalton Trans (camb Engl: 2003)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4014\/jmb.1508.08024","article-title":"In vitro antiviral activity of cinnamomum cassia and its nanoparticles against H7N3 influenza a virus","volume":"26","author":"Fatima","year":"2016","journal-title":"J Microbiol Biotechnol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"5983","DOI":"10.2147\/IJN.S425173","article-title":"Identifying the potential of miRNAs in houttuynia cordata-derived exosome-like nanoparticles against respiratory RNA viruses","volume":"18","author":"Zhu","year":"2023","journal-title":"Int J Nanomed"},{"key":"B38","doi-asserted-by":"publisher","first-page":"20240113","DOI":"10.1515\/ntrev-2024-0113","article-title":"Potential pharmaceutical applications and molecular docking study for green fabricated ZnO nanoparticles mediated raphanus sativus : in vitro and in vivo study","volume":"13","author":"Kadhum","year":"2024","journal-title":"Nanotechnol Rev"},{"key":"B39","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jphotobiol.2018.08.013","article-title":"Ultra-sonication-assisted silver nanoparticles using panax ginseng root extract and their anti-cancer and antiviral activities","volume":"188","author":"Sreekanth","year":"2018","journal-title":"J Photochem Photobiol B"},{"key":"B40","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12951-024-02473-w","article-title":"Modulation of alveolar macrophage and mitochondrial fitness by medicinal plant-derived nanovesicles to mitigate acute lung injury and viral pneumonia","volume":"22","author":"Ye","year":"2024","journal-title":"J Nanobiotechnol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.10.031","article-title":"Microparticle and nanoparticle-based influenza vaccines","volume":"376","author":"Ontiveros-Padilla","year":"2024","journal-title":"J Ctrl Rel: Off J Ctrl Rel Soc"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41563-022-01464-2","article-title":"A TLR7-nanoparticle adjuvant promotes a broad immune response against heterologous strains of influenza and SARS-CoV-2","volume":"22","author":"Yin","year":"2023","journal-title":"Nat Mater"},{"key":"B43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.actbio.2021.06.023","article-title":"From influenza to COVID-19: lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases","volume":"131","author":"Pilkington","year":"2021","journal-title":"Acta Biomater"},{"key":"B44","doi-asserted-by":"publisher","first-page":"eade4790","DOI":"10.1126\/scitranslmed.ade4790","article-title":"An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults","volume":"15","author":"Widge","year":"2023","journal-title":"Sci Transl Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.10.123","article-title":"Engineering of the PapMV vaccine platform with a shortened M2e peptide leads to an effective one dose influenza vaccine","volume":"33","author":"Carignan","year":"2015","journal-title":"Vaccine"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.01.085","article-title":"Improvement of the PapMV nanoparticle adjuvant property through an increased of its avidity for the antigen [influenza NP","volume":"30","author":"Savard","year":"2012","journal-title":"Vaccine"},{"key":"B47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12951-016-0200-2","article-title":"Influence of PapMV nanoparticles on the kinetics of the antibody response to flu vaccine","volume":"14","author":"Rioux","year":"2016","journal-title":"J Nanobiotechnol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1186\/1477-3155-12-19","article-title":"PapMV nanoparticles improve mucosal immune responses to the trivalent inactivated flu vaccine","volume":"12","author":"Rioux","year":"2014","journal-title":"J Nanobiotechnol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e77084","DOI":"10.1371\/journal.pone.0077084","article-title":"A novel M2e based flu vaccine formulation for dogs","volume":"8","author":"Leclerc","year":"2013","journal-title":"PloS One"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.4161\/hv.27567","article-title":"Single-dose monomeric HA subunit vaccine generates full protection from influenza challenge","volume":"10","author":"Mallajosyula","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12101100","article-title":"Immunity and protective efficacy of a plant-based tobacco mosaic virus-like nanoparticle vaccine against influenza a virus in mice","volume":"12","author":"Madapong","year":"2024","journal-title":"Vaccines"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2023.105688","article-title":"T4 bacteriophage nanoparticles engineered through CRISPR provide a versatile platform for rapid development of flu mucosal vaccines","volume":"217","author":"Li","year":"2023","journal-title":"Antiviral Res"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13010070","article-title":"T4 phage displaying dual antigen clusters against H3N2 influenza virus infection","volume":"13","author":"Liu","year":"2025","journal-title":"Vaccines"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0305-x","article-title":"Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses","volume":"20","author":"Kanekiyo","year":"2019","journal-title":"Nat Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"4534","DOI":"10.1038\/s41598-024-54876-2","article-title":"Mosaic quadrivalent influenza vaccine single nanoparticle characterization","volume":"14","author":"Yang","year":"2024","journal-title":"Sci Rep"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s12274-023-5395-6","article-title":"Self-assembled multiepitope nanovaccine based on NoV P particles induces effective and lasting protection against H3N2 influenza virus","volume":"16","author":"Nie","year":"2023","journal-title":"Nano Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.07.139","article-title":"A candidate dual vaccine against influenza and noroviruses","volume":"29","author":"Xia","year":"2011","journal-title":"Vaccine"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00934","article-title":"Mucosal immunity and protective efficacy of intranasal inactivated influenza vaccine is improved by chitosan nanoparticle delivery in pigs","volume":"9","author":"Dhakal","year":"2018","journal-title":"Front Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13567-020-00762-4","article-title":"Intranasally administered protein coated chitosan nanoparticles encapsulating influenza H9N2 HA2 and M2e mRNA molecules elicit protective immunity against avian influenza viruses in chickens","volume":"51","author":"Hajam","year":"2020","journal-title":"Vet Res"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.02.072","article-title":"Nasal vaccination with r4M2e.HSP70c antigen encapsulated into N-trimethyl chitosan (TMC) nanoparticulate systems: preparation and immunogenicity in a mouse model","volume":"36","author":"Dabaghian","year":"2018","journal-title":"Vaccine"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1519866","article-title":"Adjuvant-free, self\u2013assembling ferritin nanoparticle vaccine coupled with influenza virus hemagglutinin protein carrying M1 and PADRE epitopes elicits cross-protective immune responses","volume":"16","author":"Zhao","year":"2025","journal-title":"Front Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1483720","article-title":"The self-assembled nanoparticle-based multi-epitope influenza mRNA vaccine elicits protective immunity against H1N1 and B influenza viruses in mice","volume":"15","author":"Di","year":"2024","journal-title":"Front Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1361323","article-title":"A ferritin nanoparticle vaccine based on the hemagglutinin extracellular domain of swine influenza a (H1N1) virus elicits protective immune responses in mice and pigs","volume":"15","author":"Tang","year":"2024","journal-title":"Front Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1021\/acsbiomaterials.2c00219","article-title":"Structural stability and antigenicity of universal equine H3N8 hemagglutinin trimer upon release from polyanhydride nanoparticles and pentablock copolymer hydrogels","volume":"8","author":"Siddoway","year":"2022","journal-title":"ACS Biomater Sci Eng"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2019.108401","article-title":"Evaluation of CpG-ODN-adjuvanted polyanhydride-based intranasal influenza nanovaccine in pigs","volume":"237","author":"Dhakal","year":"2019","journal-title":"Vet Microbiol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.836274","article-title":"R848 adjuvant laden with self-assembled nanoparticle-based mRNA vaccine elicits protective immunity against H5N1 in mice","volume":"13","author":"Zhuang","year":"2022","journal-title":"Front Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41541-024-00963-4","article-title":"CircRNA based multivalent neuraminidase vaccine induces broad protection against influenza viruses in mice","volume":"9","author":"Yue","year":"2024","journal-title":"NPJ Vaccines"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1334670","article-title":"mRNA vaccines encoding computationally optimized hemagglutinin elicit protective antibodies against future antigenically drifted H1N1 and H3N2 influenza viruses isolated between 2018-2020","volume":"15","author":"Allen","year":"2024","journal-title":"Front Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S178809","article-title":"Liposomal nanoparticle-based conserved peptide influenza vaccine and monosodium urate crystal adjuvant elicit protective immune response in pigs","volume":"13","author":"Dhakal","year":"2018","journal-title":"Int J Nanomed"},{"key":"B70","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jconrel.2015.11.006","article-title":"PEG modified liposomes containing CRX-601 adjuvant in combination with methylglycol chitosan enhance the murine sublingual immune response to influenza vaccination","volume":"223","author":"Oberoi","year":"2016","journal-title":"J Ctrl Rel: Off J Ctrl Rel Soc"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01006-22","article-title":"Respiratory vaccination with hemagglutinin nanoliposomes protects mice from homologous and heterologous strains of influenza virus","volume":"96","author":"Sia","year":"2022","journal-title":"J Virol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jconrel.2016.12.039","article-title":"Biodegradable nanoparticle delivery of inactivated swine influenza virus vaccine provides heterologous cell-mediated immune response in pigs","volume":"247","author":"Dhakal","year":"2017","journal-title":"J Ctrl Rel: Off J Ctrl Rel Soc"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s11095-023-03540-x","article-title":"Validation of multi-epitope peptides encapsulated in PLGA nanoparticles against influenza a virus","volume":"40","author":"Heng","year":"2023","journal-title":"Pharm Res"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8030519","article-title":"Adjuvantation of an influenza hemagglutinin antigen with TLR4 and NOD2 agonists encapsulated in poly(D,L-lactide-Co-glycolide) nanoparticles enhances immunogenicity and protection against lethal influenza virus infection in mice","volume":"8","author":"Tukhvatulin","year":"2020","journal-title":"Vaccines"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.07.032","article-title":"M2e conjugated gold nanoparticle influenza vaccine displays thermal stability at elevated temperatures and confers protection to ferrets","volume":"39","author":"Ingrole","year":"2021","journal-title":"Vaccine"},{"key":"B76","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.antiviral.2017.01.021","article-title":"Consensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza a viruses","volume":"141","author":"Tao","year":"2017","journal-title":"Antiviral Res"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119308","article-title":"Silver nanoparticle-adjuvanted vaccine protects against lethal influenza infection through inducing BALT and IgA-mediated mucosal immunity","volume":"217","author":"Sanchez-Guzman","year":"2019","journal-title":"Biomaterials"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.07.016","article-title":"Calcium phosphate nanoparticle (CaPNP) for dose-sparing of inactivated whole virus pandemic influenza a (H1N1) 2009 vaccine in mice","volume":"35","author":"Mor\u00e7\u00f6l","year":"2017","journal-title":"Vaccine"},{"key":"B79","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1208\/s12249-019-1530-9","article-title":"Influenza a(H5N1) virus subunit vaccine administered with CaPNP adjuvant induce high virus neutralization antibody titers in mice","volume":"20","author":"Morcol","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.3c01829","article-title":"An Intranasal Multivalent Epitope-Based Nanoparticle Vaccine Confers Broad Protection against Divergent Influenza Viruses","volume":"17","author":"Pan","year":"2023","journal-title":"ACS Nano"},{"key":"B81","doi-asserted-by":"publisher","first-page":"eaau0810","DOI":"10.1126\/science.aau0810","article-title":"Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity","volume":"367","author":"Wang","year":"2020","journal-title":"Sci"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2022.819969","article-title":"Natural products and nanotechnology against coronavirus disease 2019","volume":"10","author":"Zeng","year":"2022","journal-title":"Front Chem"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.0c22381","article-title":"State-of-the-art of nanodiagnostics and nanotherapeutics against SARS-CoV-2","volume":"13","author":"Derakhshan","year":"2021","journal-title":"ACS Appl Mater Interfaces"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2022.12.022","article-title":"Plant-derived nanovesicles: further exploration of biomedical function and application potential","volume":"13","author":"Li","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"B85","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ymthe.2020.11.030","article-title":"Plant exosome-like nanovesicles: emerging therapeutics and drug delivery nanoplatforms","volume":"29","author":"Dad","year":"2021","journal-title":"Mol Ther"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2006.03.004","article-title":"The effect of medicinal plants used in chinese folk medicine on RANTES secretion by virus-infected human epithelial cells","volume":"107","author":"Ko","year":"2006","journal-title":"J Ethnopharmacol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/srep45723","article-title":"Antiviral activity of chlorogenic acid against influenza a (H1N1\/H3N2) virus and its inhibition of neuraminidase","volume":"7","author":"Ding","year":"2017","journal-title":"Sci Rep"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a038448","article-title":"Next-generation influenza vaccines","volume":"11","author":"Kanekiyo","year":"2021","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B89","unstructured":"Flu Vaccines Work\n          \n          2024"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0056-x","article-title":"Next-generation influenza vaccines: opportunities and challenges","volume":"19","author":"Wei","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2015.05.023","article-title":"Current and next generation influenza vaccines: formulation and production strategies","volume":"94","author":"Soema","year":"2015","journal-title":"Eur J Pharm Biopharm: Off J Arb Fur Pharm Verfahr E.v"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01835-10","article-title":"Norovirus P particle, a novel platform for vaccine development and antibody production","volume":"85","author":"Tan","year":"2011","journal-title":"J Virol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.0c00383","article-title":"Engineered nanoparticle applications for recombinant influenza vaccines","volume":"18","author":"Sia","year":"2021","journal-title":"Mol Pharmaceut"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2006.07.009","article-title":"Adaptations of nanoscale viruses and other protein cages for medical applications","volume":"2","author":"Lee","year":"2006","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"B95","doi-asserted-by":"publisher","first-page":"eabe5449","DOI":"10.1126\/scitranslmed.abe5449","article-title":"Broad neutralization of H1 and H3 viruses by adjuvanted influenza HA stem vaccines in nonhuman primates","volume":"13","author":"Darricarr\u00e8re","year":"2021","journal-title":"Sci Transl Med"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/fty070","article-title":"Simultaneous formulation of influenza vaccine and chitosan nanoparticles within CpG oligodesoxi nucleotides leads to dose-sparing and protects against lethal challenge in the mouse model","volume":"76","author":"Sadati","year":"2018","journal-title":"Pathog Dis"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines6020020","article-title":"New kids on the block: RNA-based influenza virus vaccines","volume":"6","author":"Scorza","year":"2018","journal-title":"Vaccines"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-021-00676-9","article-title":"Nano\/microparticle formulations for universal influenza vaccines","volume":"24","author":"Hendy","year":"2022","journal-title":"AAPS J"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2020.108894","article-title":"Polyethylenimine-coated PLGA nanoparticles-encapsulated angelica sinensis polysaccharide as an adjuvant for H9N2 vaccine to improve immune responses in chickens compared to alum and oil-based adjuvants","volume":"251","author":"Gu","year":"2020","journal-title":"Vet Microbiol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12080902","article-title":"Intranasal delivery of quillaja brasiliensis saponin-based nanoadjuvants improve humoral immune response of influenza vaccine in aged mice","volume":"12","author":"Silveira","year":"2024","journal-title":"Vaccines"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9111350","article-title":"ISCOM-like nanoparticles formulated with quillaja brasiliensis saponins are promising adjuvants for seasonal influenza vaccines","volume":"9","author":"Rivera-Patron","year":"2021","journal-title":"Vaccines"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e15482","article-title":"Conventional and advanced detection techniques of foodborne pathogens: a comprehensive review","volume":"9","author":"Kabiraz","year":"2023","journal-title":"Heliyon"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1039\/c7ay00048k","article-title":"Nanotechnology-based analytical approaches for detection of viruses","volume":"9","author":"Vaculovicova","year":"2017","journal-title":"Anal Methods"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1002\/tcr.202000087","article-title":"Functionalized gold nanoparticles: synthesis, properties and biomedical applications","volume":"20","author":"Fan","year":"2020","journal-title":"Chem Rec (n Y NY)"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3390\/s23198172","article-title":"Gold nanoparticle-based colorimetric sensors: properties and application in detection of heavy metals and biological molecules","volume":"23","author":"Kusuma","year":"2023","journal-title":"Sens (basel Switz)"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.matpr.2022.06.563","article-title":"Synthesis of large and stable colloidal gold nanoparticles (AuNPs) by seeding-growth method","volume":"66","author":"Yahaya","year":"2022","journal-title":"Mater Today Proc"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2015.07.006","article-title":"Trace colorimetric detection of Pb2 + using plasmonic gold nanoparticles and silica\u2013gold nanocomposites","volume":"124","author":"Thatai","year":"2016","journal-title":"Microchem J"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1021\/nn5002485","article-title":"Analysis of influenza virus receptor specificity using glycan-functionalized gold nanoparticles","volume":"8","author":"Wei","year":"2014","journal-title":"ACS Nano"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2024.120054","article-title":"Nanoparticle electrochemical biosensors for virus detection","volume":"566","author":"Baskar","year":"2025","journal-title":"Clin Chim Acta"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2021.339134","article-title":"A homogeneous nucleic acid assay for simultaneous detection of SARS-CoV-2 and influenza a (H3N2) by single-particle inductively coupled plasma mass spectrometry","volume":"1186","author":"Xu","year":"2021","journal-title":"Anal Chim Acta"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1002\/asi.20317","article-title":"CiteSpace II: detecting and visualizing emerging trends and transient patterns in scientific literature","volume":"57","author":"Chen","year":"2006","journal-title":"J Am Soc Inf Sci Technol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: VOSviewer, a computer program for bibliometric mapping","volume":"84","author":"van Eck","year":"2010","journal-title":"Scientometrics"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.joi.2017.08.007","article-title":"bibliometrix : an R-tool for comprehensive science mapping analysis","volume":"11","author":"Aria","year":"2017","journal-title":"J Informetr"},{"key":"B114","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.ymthe.2024.02.021","article-title":"Plant-derived vesicle-like nanoparticles: a new tool for inflammatory bowel disease and colitis-associated cancer treatment","volume":"32","author":"Fang","year":"2024","journal-title":"Mol Ther: J Am Soc Gene Ther"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1553915","article-title":"Unveiling the dynamic trends of plant-derived exosome nanovesicles-based theranostics: through bibliometric and visualized analysis","volume":"12","author":"Cao","year":"2025","journal-title":"Front Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1715271\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T05:38:04Z","timestamp":1768973884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1715271\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":115,"alternative-id":["10.3389\/fimmu.2026.1715271"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1715271","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"article-number":"1715271"}}